Media, investors, advocacy organizations and others, please contact us here.

Events Nephrology

National Kidney Foundation – Spring Clinical Meeting (NKF-SCM)

Information Type

Event Materials 5

Posters IgAN

Proteinuria and its association with disease progression in IgA nephropathy: Analysis of the UK National RaDaR IgA nephropathy cohort

Posters FSGS

Long-Term Sparsentan Treatment in FSGS in the DUET Open-Label Extension (OLE)

Posters IgAN

Rapid and Sustained Proteinuria Reduction With Sparsentan in Immunoglobulin A Nephropathy (IgAN): PROTECT Study Interim Results

Posters FSGS

Long-Term Sparsentan Treatment in Young Patients With Focal Segmental Glomerulosclerosis (FSGS) in the DUET Open-Label Extension (OLE)

Posters IgAN

Proteinuria and its association with disease progression in IgA nephropathy: Analysis of the UK national RaDaR IgA nephropathy cohort

Contact Us

For more information, please click on the link below to be directed to our contact us form.

Adverse Event Reporting

To report suspected adverse reactions, contact Travere Therapeutics at 1-877-659-5518 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.